Dr. Mark JC Nuijten is a pioneer in the field of nutrition-economics and has been the first classical health economist applying and developing health economic methodologies for nutritionals leading to many publications and presentations. He is academic supervisor of PhD programs at the University of Maastricht (nutrition-economics in malnutrition and obesity) and the University of Groningen (stratified medicine) in The Netherlands and founder of the ISPOR Special Interest Group on nutrition-economics. Dr. Nuijten has performed over the last 6 years more than 15 projects both for medical nutrition and consumer markets, which have resulted in numerous publications. Examples of clients are Nestle, Danone, Abbott and DSM, in addition to biotech companies in filed of nutrition.  


Systematic review and overview of health economic evaluation models in obesity prevention and therapy.  Expert Rev Pharmacoecon Outcomes Res. 2016 Sep 9:1-10. [Epub ahead of print]  

Cost-effectiveness in Clostridium difficile treatment decision-making. World J Clin Cases. 2015 Nov 16;3(11):935-41. doi: 10.12998/wjcc.v3.i11.935.

Health Economics in Medical Nutrition: An Emerging Science. Nestle Nutr Inst Workshop Ser. 2015 Nov;82:129-41. doi: 10.1159/000382009. Epub 2015 Oct 20.  

Economical impact of water intake]. Prog Urol. 2015 Sep;25(10):590-7. doi: 10.1016/j.purol.2015.05.010. Epub 2015 Jun 27. French.  

Health economic modeling to assess short-term costs of maternal overweight, gestational diabetes, and related macrosomia - a pilot evaluation. Front Pharmacol. 2015 May 20;6:103.  

The view of European experts regarding health economics for medical nutrition in disease-related malnutrition. Eur J Clin Nutr. 2015 May;69(5):539-45. doi: 10.1038/ejcn.2014.280. Epub 2015 Jan 21.PMID: 25604774.

Health economics evidence for medical nutrition: are these interventions value for money in integrated care? Clinicoecon Outcomes Res. 2014 May 19;6:241-252.

Health economic analyses in medical nutrition: a systematic literature review. Clinicoecon Outcomes Res. 2014 Mar 10;6:109-24.  

Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea. Front Pharmacol. 2014 Feb 17;5:13.

The economic value of enteral medical nutrition in the management of disease-related malnutrition: a systematic review. J Am Med Dir Assoc. 2014 Jan;15(1):17-29.

Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness. J Urol. 2013 Mar;189(3):935-9.

Workshop Report: concepts and methods in the economics of nutrition--gateways to better economic evaluation of nutrition interventions. Br J Nutr. 2012 Nov 14;108(9):1714-20.  

Pharmaceutical premium price strategy: what could be applied by the medical nutrition industry? 10-14. H&PC Today - Household and Personal Care Today, Vol. 8(2) & Agro FOOD Industry Hi Tech, Vol. 24(2) - March/April 2013.

The economic costs of disease related malnutrition. Clin Nutr. 2013 Feb;32(1):136-41.

Primary prevention of nephrolithiasis is cost-effective for a national healthcare system. BJU Int. 2012 Dec;110(11 Pt C):E1060-7.

The Health Economic Impact of Oral Nutritional Supplements (ONS) in Germany Gesundheitsökonomische Analyse der medizinischen Trinknahrungen in Deutschland DOI Aktuel Ernahrungsmed 2012; 37: 126–133.  

The budget impact of oral nutritional supplements for disease related malnutrition in elderly in the community setting. Front Pharmacol. 2012;3:78.

Nutrition economics: an innovative approach to informed public health management. Eur J Pharmacol. 2011 Sep;668 Suppl 1:S133-7.

Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands. Eur J Health Econ 2010; (): .PMID: 21165666.

Studie toont aan: medische voeding werkt kostenbesparend. @live, April 2010. 12-13.
(Study shows that medical nutrition is cost saving)

Analysis of the health economic impact of medical nutrition in the Netherlands. Eur J Clin Nutr 2010; 64 (10): 1229-34.

Nutrition economics - characterising the economic and health impact of nutrition. Br J Nutr 2010; (): 1-9.  


Food for thought (but not too much) for health economic analyses of nutritional interventions in obesity. ISPOR 19th Annual European Congress. 29 October-2 November 2016, Vienna, Austria.

Developing a business case for the health care channels for your food products. Healthy Ageing Congress 2012 Conference. 15 and 6 November (2012) Frankfurt, Germany.                     

A public health perspective on a cost-saving intervention. 9th HTAI Annual Meeting 2012, Bilbao, Spain.

Health Economics in Medical Nutrition An Emerging Science. 12th Nestle Clinical Nutrition Course from October 13 -18 (2013) in New Delhi, India.

A health economic model to assess the impact of high birth weight on public health.  DOHAD 8th World Congress on developmental origins of health and disease from 17 - 20 November (2013) in Suntec, Singapore. Journal of developmental origins of health and disease. Volume 4 Supplement 2. November 2013. S174.

The health economic impact of oral nutritional supplements in Germany. Ernährung. Mitten in der Medizin. 2010. Leipzig, Germany in June 18, 2010.

Food for thought: should reimbursement criteria for pharmaceuticals also be applied to nutritionals? ISPOR 11th Annual European Congress. Athens, Greece on 8-11 November 2008.